Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease?

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 10, 2005, Pages 1099-1104

  Martins, Alexandra ^a,b   Cortez Pinto, Helena ^a,b   Machado, Mariana ^a,b   Gonçalves, Maria Sara ^a,b   Soren, Steffensen ^c   Marques Vidal, Pedro ^a   Carneiro De Moura, Miguel ^b   Camilo, Maria Ermelinda ^a,c  

^a Unidade de Nutrição e Metabolismo   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c Instituto Medicina Molecular   (Portugal)

Author keywords

Alcohol; Alcoholic liver disease; Polymorphisms

Indexed keywords

ALANINE; CD14 ANTIGEN; INTERLEUKIN 10; MANGANESE SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; VALINE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FUNCTION TEST; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; SEX RATIO;

ADULT; ALCOHOL DRINKING; ANTIGENS, CD14; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26444453224     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200510000-00014     Document Type: Article

References (30)

1. Cortez-Pinto H, Marques-Vidal P, Monteiro E. Liver disease related admissions in Portugal: clinical and demographic pattern. Eur J Gastroenterol Hepatol 2004; 16:873-877.
2. Lindros KO. Alcoholic liver disease: pathobiological aspects. J Hepatol 1995; 23:7-15.
3. Day CP, Yeaman SJ. The biochemistry of alcoholic fatty liver. Biochim Biophys Acta 1994; 1215:33-48.
4. Mezey E. Alcoholic liver disease. Prog Liver Dis 1982; 7:555-572.
5. Sorensen TI. Alcohol and liver injury: dose-related or permissive effect? Br J Addict 1989; 84:581-589.
6. Hrubec Z, Omenn GS. Evidence for genetic predispositiion to alcoholic cirrhosis and psychosis. Twin concordance for alcoholism and its end points by zygosity among male veterans. Alcohol Clin Exp Res 1981; 5:207-215.
7. Harada S, Agarwal DP, Goedde HW, Takagi S, Ishikawa B. Possible protective role against alcoholism for aldeyde dehydrogenase isozyme deficiency in Japan [Letter]. Lancet 1982; ii:827.
8. Shibuya A, Yoshida A. Genotypes of alcohol metabolizing enzymes in Japanese with alcoholic liver disease: a strong correlation of the usual Caucasian type aldeyde dehydrogenase (ALDH2-1) with disease. Am J Hum Genet 1989; 43:744-748.
9. Day CP, James OF, Bassendine MF, Crabb DW, Li TK. Alcohol dehydrogenase polymorphisms and predisposition to alcoholic cirrhosis. Hepatology 1993; 18:230-232.
10. Pirmohamed M, Kitteringham NR, Quest LJ, Allott RL, Green VJ, Gilmore IT, Park BK. Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetics 1995; 5:351-357.
11. Carr LG, Hartleroad JY, Liang Y, Mendenhall C, Moritz T, Thomasson H. Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men. Alcohol Clin Exp Res 1995; 19:182-184.
12. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990; 14:255-259.
13. Devière J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990; 11:628-634.
14. Bird GL, Sheron N, Goka AK, Alexander GL, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112:917-920.
15. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13:267-276.
16. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997; 26:143-146.
17. Ladero JM, Fernandez-Arquero M, Tudela JI, Agundez JA, Diaz-Rubio M, Benitez J, de la Concha EG. Single nucleotide polymorphisms and microsatellite alleles of tumour necrosis factor alpha and interleukin-10 genes and the risk of advanced chronic alcoholic liver disease. Liver 2002; 22:245-251.
18. Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 2000; 46:540-545.
19. Nanji AA, Khettry U, Sadrzadeh SM, Yamanaka T. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 1993; 142:367-373.
20. Rao RK, Seth A, Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004; 286:G881-G884.
21. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20:976-983.
22. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113:401-406.
23. Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001; 33:1148-1153.
24. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996; 226:561-565.
25. Degoul F, Sutton A, Mansouri A, Cepanec C, Degott C, Fromenty B, et al. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 2001; 120:1468-1474.
26. Stewart SF, Leathart JB, Chen Y, Daly AK, Rolla R, Vay D, et al. Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology 2002; 36:1355-1360.
27. Wu A, Slavin G, Levi AJ. Elevated gamma-glutamyl-transferase and histological damage in alcoholics. Am J Gastroenterol 1976; 65:318-323.
28. Cortez-Pinto H, Baptista A, Camilo E, Valente A, Saragoça A, Moura MC. Nonalcoholic steatohepatitis clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996; 41:172-179.
29. Lichy C, Meiser H, Grond-Ginsbach C, Buggle F, Dorfer C, Grau A. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population. J Neurol 2002; 249:821-823.
30. Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Controlled Clin Trials 1997; 18:274.